China
Exploring Opportunities for Foreign Companies in China’s Emerging and High-Tech Industries
China’s emerging industries offer significant opportunities for foreign investors through supportive policies and high growth potential. Key sectors include biopharmaceuticals, AI, and advanced technologies, driven by innovation-led initiatives to enhance global competitiveness and foster technological self-sufficiency.
China’s emerging industries present a plethora of new opportunities for foreign investors and companies. Highlighted as key to securing China’s future economic prosperity, these industries are bolstered by support and incentive policies, while harboring huge growth potential. We outline opportunities across five emerging industries in China.
China’s drive to develop new and emerging technologies is presenting a host of new opportunities for foreign investors and companies. This drive is anchored in its shift towards an innovation-led growth model, recently represented by concepts such as new quality productive forces (NQPFs), new-type industrialization, and “future industries”.
Central to China’s economic agenda since 2023, NQPFs prioritize the development of cutting-edge technologies, such as AI, robotics, biotechnology, and new energy and materials, to enhance global competitiveness and economic growth. Meanwhile, another core tenet of China’s growth strategy, the new-type industrialization initiative complements NQPFs by promoting advanced manufacturing, secure supply chains, and technological self-sufficiency, thereby positioning China as a leader in high-tech sectors. “Future industries“, meanwhile, focus on emerging technologies that are still in the early stages of development, such as quantum computing and 6G networks. Together, these strategies reflect China’s broader goal to drive economic growth through technological innovation and leadership in frontier industries.
Developing China’s biopharmaceutical industry is a strategic priority for the government. Recognized as a “strategic emerging industry” in the 14th Five-Year Plan (2021-2025), the biopharma sector is positioned for substantial growth, offering promising opportunities for foreign companies. According to the Qianzhan Industry Research Institute, the market size of China’s biopharmaceutical industry reached RMB 1.86 trillion (US$261.21 billion) in 2022, an 8.3 percent increase from the previous year. Between 2016 and 2020, the number of biotech science parks grew from 400 to 600, further reflecting government efforts to boost the sector.
Meanwhile, the 14th Five-Year Plan for Developing the Bio-Economy (2021-2025) outlines general development goals for the industry, such as increasing the contribution of the biopharmaceutical industry to GDP and enhancing the strategic position of biomedicine and related industries. The plan also emphasizes boosting R&D investment, increasing high-value patents, and strengthening innovation platforms.
Foreign companies are also encouraged to invest in the biopharmaceutical industry, with the sector listed in the 2022 Catalogue of Encouraged Industries for Foreign Investment (“2022 FI Encouraged Catalogue”) for multiple provinces, including Liaoning, Jilin, Heilongjiang, Henan, and Yunnan. This inclusion reflects the government’s desire to attract international expertise and capital to bolster domestic capabilities. Moreover, the government provides attractive incentive policies, such as a reduced 15 percent corporate income tax (CIT) rate for biopharmaceutical companies operating in certain development zones, including the Lingang New Area in Shanghai and the Nansha Economic Zone in Guangzhou.
China’s AI industry presents significant opportunities for foreign companies, fueled by strong government commitment, a rapidly growing market, and policies encouraging private and foreign investment. The Chinese government has prioritized AI as a key driver of innovation and is actively encouraging the integration of AI technologies across a variety of sectors, such as healthcare, education, finance, and urban management.
This article was first published by China Briefing , which is produced by Dezan Shira & Associates. The firm assists foreign investors throughout Asia from offices across the world, including in in China, Hong Kong, Vietnam, Singapore, and India . Readers may write to info@dezshira.com for more support. |
Read the rest of the original article.
Business
China Provides Clarification on the Implementation of Article 88 (1) of the New Company Law
China’s Supreme People’s Court clarified that Article 88(1) of the New Company Law won’t apply retroactively, easing concerns for prior shareholders in equity transfers before July 1, 2024.
Clarification on Article 88(1) Non-Retroactivity
The Supreme People’s Court of China has clarified that Article 88(1) of the New Company Law will not retroactively apply to equity transfer disputes occurring before July 1, 2024. This announcement aims to address concerns from existing shareholders and resolve discrepancies in judicial decisions nationwide. Companies are advised to strengthen risk management practices for future equity transactions.
Judicial Guidance and Legal Framework
On December 24, 2024, the Supreme People’s Court issued a response reaffirming that disputes tied to equity transfers before the July 1, 2024, deadline will be governed by previous laws. This decision follows inconsistencies in judicial rulings regarding capital contributions, prompting a review by the Legislative Affairs Commission, which concluded that retroactive application was not justifiable.
Risk Management Strategies Moving Forward
Despite the ruling, equity transfers after July 1, 2024, may still attract supplemental liability under Article 88(1). To mitigate these risks, businesses should consider reducing registered capital, conducting thorough risk assessments, and implementing contractual safeguards to protect against potential liabilities.
Source : China Clarifies the Application of Article 88 (1) of the New Company Law
China
China Unveils Draft Catalogue to Promote Foreign Investment
The 2024 Draft FI Encouraged Catalogue features a national and regional sub-catalogue, highlighting industries favorable for foreign direct investment in China. It expands incentives in sectors like medical devices, batteries, new energy vehicles, pet care, elderly care, and cultural tourism.
Similar to the previous version, the Draft FI Encouraged Catalogue includes two sub-catalogues – one covers the entire country (“national catalogue”) and one covers the central, western, and northeastern regions (“regional catalogue”).
Together, the FI encouraged catalogue identifies industries where foreign direct investment (FDI) will be welcome and treated with favorable policies in China.
The lengthening of the catalogue demonstrates China’s firm standing on economic opening-up and the fact that more investment fields will favor foreign investors.
Overall, the revision of the 2024 Draft Foreign Investment (FI) Encouraged Catalogue focuses on:
In specific sectors, the new Encouraged Catalogue introduces or refines incentives for areas like medical devices, batteries, new energy vehicles, pet care, elderly care, and cultural tourism, which are worth noting.
This article was first published by China Briefing , which is produced by Dezan Shira & Associates. The firm assists foreign investors throughout Asia from offices across the world, including in in China, Hong Kong, Vietnam, Singapore, and India . Readers may write to info@dezshira.com for more support. |
Read the rest of the original article.
China
Trump, Xi and Putin: a dysfunctional love triangle with stakes of global significance
Reports suggest a phone call between Donald Trump and Vladimir Putin hinted at a complex US-Russia relationship. Trump aims to exploit Russia-China tensions, potentially reshaping alliances and international dynamics.
Reports of a phone call between the US president-elect, Donald Trump, and his Russian counterpart, Vladimir Putin (although quickly denied by the Kremlin) have given a first flavour of the tone and direction of their relationship in the immediate future. According to the Washington Post, Trump spoke with Putin on November 7, warning him against any escalation in Ukraine and reminding him of “Washington’s sizeable military presence in Europe”.
Regardless of whether it happened or not, any – if even only indirect – exchange of messages between the pair should be heeded by America’s allies in the west, as well as Russia’s major partner in the east: China’s Xi Jinping. And there has been plenty of such messaging over the past few months.
Putin, earlier on the day of the alleged phone call, gave a long address at the annual meeting of the Valdai Discussion Club thinktank in the Black Sea resort of Sochi. Unsurprisingly, the speech – and Putin’s answers to questions from the audience afterwards – were anti-western and full of confidence that a new world order was now in “the phase of genuine creation”.
But at the same time, Putin took pains to flatter Trump as a “courageous man”, saying he’d consider any proposals from Trump aimed at restoring US-Russia relations and ending what Putin called the “Ukrainian crisis”.
But he then spent considerably more time making the case for the relationship between Russia and China. Here his audience was less the incoming US president and more his old friend the Chinese president.
The reason for this goes back to one of Trump’s messages to Putin and Xi. Trump told Tucker Carlson at a campaign event on October 31 that he would work to “un-unite” Russia and China. Trump implied that the two are “natural enemies” because Russia has vast territory that China covets for its population.
Donald Trump: US will ‘un-unite’ Russia and China.
Russia and China have a history of conflict over territory along their long land border in Siberia. This was part of the Sino-Soviet split in the 1960s, which preceded the US opening to China under then-president Richard Nixon in the 1970s.
In contrast to Nixon, Trump looks set to try to reset US relations with Moscow rather than Beijing. While it’s hard to imagine a similar split between Russia and China today, Trump’s apparent desire to exploit discord between Russia and China to the advantage of the US should not be dismissed as completely unrealistic either.
On the face of it, Putin and Xi are closely aligned. But a deeper dive into the relationship between Russia and China suggests it’s primarily one between their current leaders and lacks much of the institutional depth that other alliances have.
Putin and XI: a ‘new era’ of partnership between their two countries.
EPA-EFE/Maxim Shemetov/pool
There is a lot of resentment of China in Russia in both public and policy circles. Russians remain wary of China’s growing role in Central Asia and worry about the potential for disputes over long-contested borders. Many are also resentful of the fact that Moscow is now a junior partner to Beijing.
These are potentially all issues that Trump could use to drive a wedge between Russia and China. But a lot hinges on what Putin perceives is in it for Russia. This should be focusing minds in the west about what shape Trump’s Ukraine policy will take and what this means for Ukraine and the west.
A Trump-brokered agreement is likely to involve the recognition of Russian territorial gains in Ukraine since 2014, complete sanctions relief and broad international rehabilitation granted to Moscow. It would surely also involve a down-scaling of the US commitment to Nato and a pledge not to pursue further enlargement of the alliance.
Trump might get a deal with Putin, but whether Putin would stick to it is questionable. Putin is much more likely to simply play both sides in the hope that Russia might in this way become a third peer alongside China and the US in an emerging new international order.
This is of course a complete fantasy given the size of the Russian economy alone, but unlikely to affect Putin’s calculations, given his longing to restore Russia’s superpower status.
Chinese leverage
An American opening to Moscow, as opposed to Beijing, is also difficult to imagine because America’s European partners are unlikely to go along with it. Some, like Hungary’s Viktor Orbán and Slovakia’s Robert Fico might find the idea attractive in general, but Germany and France, among others in the EU, are more likely to want to make a deal with China.
The reason for this is economic – they have largely overcome their dependence on Russian oil and gas, but not on China as an export market.
Shared values? Donald Trump and Vladimir Putin at the commemoration of the 100th anniversary of the 1918 armistice.
EPA-EFE/Ludovic Marin
Beijing, meanwhile, won’t sit idly by while Trump tries to drive a wedge between Russia and China. Despite Putin’s efforts to build parallel relations with North Korea and Iran, Xi retains plenty of economic leverage over Russia and is going to use it to keep Russia on side.
Diplomatically, Putin depends on Xi and China-led outfits such as the Shanghai Cooperation Organisation and the Brics. While there are differences between Moscow and Beijing, they also both share a world view of a US in terminal decline – which is now likely to be further accelerated by the upheaval expected from a second Trump term.
For China in particular, preventing the US from completely pivoting to the Indo-Pacific will be a key priority – and not allowing Trump to cut a deal with Putin at China’s expense will be high on Xi’s agenda as a means to achieving that end.
Trump might still try to open up to Russia by striking a deal with Putin over Ukraine. But such a deal with Putin is not the same as dividing Russia and China. On the contrary, it is more likely to “un-unite” Europe and the US and to further weaken the transatlantic alliance.
Rather than making America great again, Trump could further hasten its decline by mistaking the destruction of what is left of the liberal international order with its reshaping according to US interests.
This article is republished from The Conversation under a Creative Commons license. Read the original article.